49 results
Page 2 of 3
8-K
EX-10.1
bwi1dm
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.1
9gxc4jylef7awya5yrh
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
8-K
EX-10.4
4m0czxysw1cgzuh4ov
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-10.1
4x3ae
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-3.5
xuqqk7 3v1fo
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.11
zg91ka384o7a05 fc
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-14.1
awtd 0ft0
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
S-4/A
EX-10.54
if97sxnm8 o0d5c4lqu
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
8-K
EX-2.1
4c6bnwzjy2 9e
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-2.1
ndj o37fyu9u6
21 Jan 20
Business combination disclosure
9:19am
8-K
EX-10.1
5g97ru
6 Nov 19
Entry into a Material Definitive Agreement
9:56pm
424B3
vgj9og0mlzj9o9hegq7
6 Aug 19
Prospectus supplement
4:45pm
8-K
EX-10.1
c6aijspq8bwydnu
24 Jul 19
Entry into a Material Definitive Agreement
5:29pm
424B3
i9ybmrj eijhgmq
3 Dec 18
Prospectus supplement
6:02am